American Journal of Cardiology
Volume 98, Issue 3 , Pages 362-366 , 1 August 2006

Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery

  • Goran Stankovic, MD

      Affiliations

    • Institute for Cardiovascular Diseases, Clinical Center of Serbia, Belgrade, Serbia and Montenegro.
    • ,
  • John Cosgrave, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • ,
  • Alaide Chieffo, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • San Raffaele Hospital, Milan, Italy
    • ,
  • Ioannis Iakovou, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • ,
  • Giuseppe Sangiorgi, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • ,
  • Matteo Montorfano, MD

      Affiliations

    • San Raffaele Hospital, Milan, Italy
    • ,
  • Flavio Airoldi, MD

      Affiliations

    • San Raffaele Hospital, Milan, Italy
    • ,
  • Mauro Carlino, MD

      Affiliations

    • San Raffaele Hospital, Milan, Italy
    • ,
  • Iassen Michev, MD

      Affiliations

    • San Raffaele Hospital, Milan, Italy
    • ,
  • Leo Finci, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • ,
  • Antonio Colombo, MD

      Affiliations

    • EMO Centro Cuore Columbus, Milan, Italy
    • San Raffaele Hospital, Milan, Italy
    • Corresponding Author InformationCorresponding author: Tel: 39-02-481-2920; fax: 39-02-4819-3433.

Received 23 November 2005 ,Revised 31 January 2006 ,Accepted 31 January 2006.

References 

  1. Flaherty JD , Davidson CJ . Diabetes and coronary revascularization . JAMA . 2005;293:1501–1508
  2. Prasad A, Stone GW, Stuckey TD, Costantini CO, Zimetbaum PJ, McLaughlin M, et al. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction . J Am Coll Cardiol . 2005;45:508–514
  3. West NE, Ruygrok PN, Disco CM, Webster MW, Lindeboom WK, O’Neill WW, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients . Circulation . 2004;109:867–873
  4. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus (the TAXUS-IV trial) . J Am Coll Cardiol . 2005;45:1172–1179
  5. Moussa I, Leon MB, Baim DS, O’Neill WW, Popma JJ, Buchbinder M, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients (a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy) . Circulation . 2004;109:2273–2278
  6. Orlic D, Bonizzoni E, Stankovic G, Airoldi F, Chieffo A, Corvaja N, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation (immediate and mid-term results) . J Am Coll Cardiol . 2004;43:1154–1160
  7. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents . JAMA . 2005;293:2126–2130
  8. Serruys P, Ong A, Morice MC, De Bruyne B, Colombo A, Macaya C, et al. Arterial Revascularisation Therapies Study Part II—sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions . EuroInterv . 2005;1:147–156
  9. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al  Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization . N Engl J Med . 2005;353:653–662
  10. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients . N Engl J Med . 2005;353:663–670
  11. Goy JJ , Stauffer JC , Siegenthaler M , Benoit A , Seydoux C . A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology (the TAXi trial) . J Am Coll Cardiol . 2005;45:308–311
  12. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis (a randomized controlled trial) . JAMA . 2005;293:165–171
  13. de Lezo J, Medina A, Pan M, Romero M, Delgado A, Segura J, et al  Drug-eluting stents for complex lesions (randomized rapamycin versus paclitaxel CORPAL study) . (abstr) J Am Coll Cardiol . 2005;45:75A–76A
  14. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, et al. Sirolimus vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial . JAMA . 2006;295:895–904
  15. Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, Tsuchida K, et al  Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries) . Am J Cardiol . 2005;96:358–362
  16. Briguori C , Condorelli G , Airoldi F , Mikhail GW , Ricciardelli B , Colombo A . Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients . Heart . 2004;90:1481–1482

PII: S0002-9149(06)00722-3

doi: 10.1016/j.amjcard.2006.01.104

American Journal of Cardiology
Volume 98, Issue 3 , Pages 362-366 , 1 August 2006

Article Tools